Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.

Booth L, Adams R, Clifford A, Aguilar F, Ali N, Bishop C, Sufi J, Wu Y, Fitzpartick A, Geh JLC, MacKenzie Ross AD, Lloyd-Hughes H, Stodell M, Daniel CS, Whittaker S, Sinha K, Willsmore ZN, Terranova-Barberio M, Ali N, Lacy KE, Tull TJ, Tsoka S, Karagiannis SN

Open source

DOI: 10.1136/jitc-2026-015585
Published: 2026 Aug 7
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-015585,
  title = {Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.},
  author = {Booth L and Adams R and Clifford A and Aguilar F and Ali N and Bishop C and Sufi J and Wu Y and Fitzpartick A and Geh JLC and MacKenzie Ross AD and Lloyd-Hughes H and Stodell M and Daniel CS and Whittaker S and Sinha K and Willsmore ZN and Terranova-Barberio M and Ali N and Lacy KE and Tull TJ and Tsoka S and Karagiannis SN},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2026-015585},
  url = {https://doi.org/10.1136/jitc-2026-015585}
}

RIS

TY  - JOUR
TI  - Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.
AU  - Booth L
AU  - Adams R
AU  - Clifford A
AU  - Aguilar F
AU  - Ali N
AU  - Bishop C
AU  - Sufi J
AU  - Wu Y
AU  - Fitzpartick A
AU  - Geh JLC
AU  - MacKenzie Ross AD
AU  - Lloyd-Hughes H
AU  - Stodell M
AU  - Daniel CS
AU  - Whittaker S
AU  - Sinha K
AU  - Willsmore ZN
AU  - Terranova-Barberio M
AU  - Ali N
AU  - Lacy KE
AU  - Tull TJ
AU  - Tsoka S
AU  - Karagiannis SN
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-015585
UR  - https://doi.org/10.1136/jitc-2026-015585
ER  -

APA

L, B., R, A., A, C., F, A., N, A., C, B., J, S., Y, W., A, F., JLC, G., AD, M. R., H, L., M, S., CS, D., S, W., K, S., ZN, W., M, T., N, A., KE, L., TJ, T., S, T., & SN, K. (2026). Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2026-015585

Source records

pubmed · retrieved 2026-09-26T12:52:36.196Z